VANCONEX LYOPHILIZED POWDER FOR INJECTION 500MG/VIAL
Product details
Registration number: SIN16014P
Classification: Prescription Only
Active ingredients: Vancomycin Hydrochloride 512.59 mg/vial eqv Vancomycin
Strength: 500 mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: HETERO SINGAPORE PTE. LTD.
ATC code: J01XA01
HSA approval date: 24 September 2020
Manufacturer(s): Aspiro Pharma Limited
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for VANCONEX LYOPHILIZED POWDER FOR INJECTION 500MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16014P
Classification: Prescription Only
What active ingredients and strength are recorded for VANCONEX LYOPHILIZED POWDER FOR INJECTION 500MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Vancomycin Hydrochloride 512.59 mg/vial eqv Vancomycin
Strength: 500 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for VANCONEX LYOPHILIZED POWDER FOR INJECTION 500MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for VANCONEX LYOPHILIZED POWDER FOR INJECTION 500MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: HETERO SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for VANCONEX LYOPHILIZED POWDER FOR INJECTION 500MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Aspiro Pharma Limited
Manufacturing country/countries: INDIA
Where can I look up VANCONEX LYOPHILIZED POWDER FOR INJECTION 500MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16014P or the exact product name VANCONEX LYOPHILIZED POWDER FOR INJECTION 500MG/VIAL. The general register link does not preselect this product.
What are the source dates for this VANCONEX LYOPHILIZED POWDER FOR INJECTION 500MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this VANCONEX LYOPHILIZED POWDER FOR INJECTION 500MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16014P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)